Category

Attention Deficit & Disruptive Behavior Disorders

Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial.

By | Attention Deficit & Disruptive Behavior Disorders

Authors: Ruth E. Cooper, Emma Williams, Seth Seegobin, Charlotte Tye, Jonna Kuntsi, Philip Asherson
European Neuropsychopharmacology, August 2017

Adults with ADHD describe self-medicating with cannabis, with some reporting a preference for cannabis over ADHD medications. A small number of psychiatrists in the US prescribe cannabis medication for ADHD, despite there being no evidence from randomised controlled studies…

Read More

The impact of ADHD persistence, recent cannabis use, and age of regular cannabis use onset on subcortical volume and cortical thickness in young adults.

By | Attention Deficit & Disruptive Behavior Disorders

Authors: Krista M. Lisdahl, Leanne Tamm, Jeffery N. Epstein, Terry Jernigan, Brooke S. G. Molina, et al
Drug and Alcohol Dependence, 1 April 2016

BACKGROUND: Both Attention Deficit Hyperactivity Disorder (ADHD) and chronic cannabis (CAN) use have been associated with brain structural abnormalities, although little is known about the effects of both in young adults. METHODS: Participants included: those with a childho…

Read More

Successful authorised therapy of treatment resistant adult ADHD with Cannabis: experience from a medical practice with 30 patients

By | Attention Deficit & Disruptive Behavior Disorders

Authors: Eva Milz, Franjo Grotenhermen
Conference Poster, 2015

The medical certificates of 30 patients with adult ADHD, who were granted approval by the German Health Ministry to use cannabis flowers between 2012 and 2014, were analysed with regard to course of disease, previous treatment efforts, and effects of self-medi…

Read More

Association of the cannabinoid receptor gene (CNR1) with ADHD and post‐traumatic stress disorder.

By | Attention Deficit & Disruptive Behavior Disorders, Stress Disorders - Post-Traumatic

Authors: Ake T. Lu, Matthew N. Ogdie, Marjo‐Ritta Järvelin, Irma K. Moilanen, Sandra K. Loo, et al
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 22 January 2008

Attention deficit hyperactivity disorder (ADHD) is a highly heritable disorder affecting some 5-10% of children and 4-5% of adults. The cannabinoid receptor gene (CNR1) is a positional candidate gene due to its location near an identified ADHD linkage peak on chromosome 6, its…

Read More